Cetya Therapeutics

A pioneering leader in histone deacetylase inhibitor research, focusing on largazole analogs.

News

Colorado Institute for Drug, Device, and Diagnostic Development Investment
1 Feb

Colorado Institute for Drug, Device, and Diagnostic Development Investment

Investment from Colorado Institute for Drug, Device and Diagnostic Development will advance oncology drug development Cetya Therapeutics, Inc. ann...
Issuance of Third Patent on Largazole Analogs
14 Dec

Issuance of Third Patent on Largazole Analogs

Cetya Therapeutics, Inc. announces the issuance of a third patent to Colorado State University Ventures covering its proprietary portfolio of analogs ...

About

Collaborations

Research and Development